Nav: Home

Scaling up a nanoimmunotherapy for atherosclerosis through preclinical testing

August 21, 2019

By integrating translational imaging techniques with improvements to production methods, Tina Binderup and colleagues have scaled up a promising nanoimmunotherapy for atherosclerosis in mice, rabbits and pigs - surmounting a major obstacle in nanomedicine. Their study brings the anti-inflammatory treatment for one of the most common chronic conditions worldwide closer to application in humans and identifies strategies for overcoming challenges in translating nanoimmunotherapies from small animal models to the clinic. Nanomedicine - the use of nanotechnology and nanomaterials to treat disease - has become a major field of interest, and hundreds of new nanoformulations are being developed every year. However, most nanomedicine research is limited to proof-of-concept studies in mice, and challenges in producing enough nanomaterials have hampered larger animal testing and the approval of practical and effective drugs for humans. In a previous study, the researchers created a nanotherapeutic called S-HDL that reduced inflammation in blood vessels in mouse models of atherosclerosis. Here, they tested a new production method for S-HDL based on devices named microfluidizers, which boosted production rates of the therapeutic by up to 80-fold compared to older methods. The authors used PET and MRI imaging to visualize how the new S-HDL formulation performed in rabbits and a pig model of atherosclerosis and found two weeks of the treatment halted the accumulation of plaque and curtailed vessel wall inflammation in the animals without causing toxicity. Binderup et al. say their new workflow and use of noninvasive imaging could allow researchers to gather meaningful results even when restricted to using small groups of larger animals.

American Association for the Advancement of Science

Related Science Articles:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.
Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.
Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.
Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.
Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.
More Science News and Science Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...